A new study shows that a vaccine produced by a Vancouver, B.C.-based company has better than expected results.
The HPV vaccine developed by Canadian company Chimerix, for example, is significantly less likely to cause cervical cancer compared with a vaccine administered by a San Francisco-based company.
The study is the first to examine the effectiveness of two vaccines, both of which have been used widely since the 1980s.
Researchers said that while both vaccines have shown significant benefits in preventing cervical cancer, they did not fully understand how the vaccines work.
“I think we have really not understood the mechanisms of how the HPV vaccine works, and I think that’s been one of the challenges of this work,” said Dr. James Lacey, the lead author of the study.
The HPV vaccination is produced by Chimerux, which was founded by Dr. Bruce Lee in the late 1990s.
It is marketed as the world’s first cervical cancer vaccine.
It has been used for about 20 years, with more than 4 million doses administered around the world.
In Canada, Chimerax vaccines are administered to people between the ages of 15 and 64, including women who have had an abortion or who are considering it.
Vaccination is not mandatory for most people in the country.
Since the start of the new vaccine, more than half of the U.S. population has received a vaccine.
The vaccine was developed by Merck Vaccines Inc., which was acquired by Novartis AG in 2008.
But the vaccine has been a divisive issue in the U!
S., and there have been concerns about safety, particularly with regard to the HPV type 16.
Studies have shown that the vaccine is significantly safer than other vaccines administered in the United States.
The vaccines have been linked to fewer side effects, including fewer hospitalizations and deaths, but some have raised questions about their efficacy.
It is also a controversial topic in Canada, where several provinces and territories have passed laws banning the use of vaccines containing the HPV types 16 and 18.
The federal government is working to repeal the laws.
Chimerix said the vaccine will be administered to approximately one million Canadians over the next three years.
Scientists said it would be possible to develop a vaccine that would prevent cervical cancer by 2036.
But there are other potential ways to prevent cervical cancers.
Dr. Andrew Yaffe, a member of the Advisory Committee on Immunization Practices for the U,S.
Centers for Disease Control and Prevention, said the HPV vaccination could help prevent other cancers.
“This is an important first step, but it’s just the first step,” he said.
There are several other vaccines being developed that are effective in preventing HPV types that cause cervical cancers, including the Gardasil vaccine.
For more health news, visit MTV News.